Change in forced expiratory time and spirometric performance during a single pulmonary function testing session

Respiratory Care

Volumn 51, Issue 3, 2006, Pages 246-251

  Tsai, Adam G ^a   Christie, Jason D ^b   Gaughan, Christina A ^b   Palma Jr , Wenceslao R ^c   Margolis, Mitchell L ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Forced expiratory time; Pulmonary function test

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; EXPIRATORY FLOW RATE; FEMALE; FORCED EXPIRATION; FORCED EXPIRATORY VOLUME; GOVERNMENT; HUMAN; LABORATORY TEST; LUNG FLOW VOLUME CURVE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SPIROMETRY; STATISTICAL SIGNIFICANCE; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SPIROMETRY; UNITED STATES;

EID: 33745910241     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152(3):1107-1136.
2. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144(5):1202-1218.
3. Rozas CJ, Goldman AL. Daily spirometric variability: normal subjects and subjects with chronic bronchitis with and without airflow obstruction. Arch Intern Med 1982;142(7):1287-1291.
4. Pennock BE, Rogers RM, McCaffree DR. Changes in measured spirometric indices. What is significant? Chest 1981;80(1):97-99.
5. Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma.' Chest 1997;112(5):1234-1240.
6. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39(2):131-136.
7. Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled β-agonist treatment. Respir Med 2000; 94(8):767-771.
8. Anthonisen NR, Wright EC. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133(5):814-819.
9. Reddy R, Cook T, Tenholder MF. Bronchodilatation and the inspiratory flow volume curve. Chest 1996;110(5):1226-1228.
10. Gimeno F, Postma DS, van Altena R. Plethysmographic parameters in the assessment of reversibility of airways obstruction in patients with clinical emphysema. Chest 1993;104(2):467-470.
11. Pellegrino R, Rodarte JR, Brusasco V. Assessing the reversibility of airway obstruction. Chest 1998;114(6):1607-1612.
12. Taube C, Lehnigk B, Paasch K, Kirsten DK, Jorres RA, Magnussen H. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162(1):216-220.
13. Smith HR, Irvin CG, Cherniack RM. The utility of spirometry in the diagnosis of reversible airways obstruction. Chest 1992;101(6):1577-1581.
14. O'Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? Chest 2000;117(2 Suppl):42S-47S.
15. Guyatt GH, Townsend M, Nogradi S, Pugsley SO, Keller JL, Newhouse MT. Acute response to bronchodilator: an imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med 1988;148(9):1949-1952.
16. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160(2):542-549.
17. Girard WM, Light RW. Should the FVC be considered in evaluating response to bronchodilator? Chest 1983;84(1):87-89.
18. Wise RA, Kanner RE, Lindgren P, Connett JE, Altose MD, Enright PL, Tashkin DP; Lung Health Study Research Group. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 2003;124(2):449-458.
19. Sorensen JB, Morris AH, Crapo RO, Gardner RM. Selection of the best spirometric values for interpretation. Am Rev Respir Dis 1980; 122(5):802-805.
20. Koyama H, Nishimura K, Ikeda A, Tsukino M, Izumi T. A comparison of different methods of spirometric measurement selection. Respir Med 1998;92(3):498-504.
21. Macdonald JB, Cole TJ, Seaton A. Forced expiratory time: its reliability as a lung function test. Thorax 1975;30(5):554-559.
22. Hansen JE, Casaburi R, Goldberg AS. A statistical approach for assessment of bronchodilator responsiveness in pulmonary function testing. Chest 1993;104(4):1119-1126.
23. Larsson K, Hedenstrom H, Malmberg P. Learning effects, variation during office hours and reproducibility of static and dynamic spirometry. Respiration 1987;51(3):214-222.
24. Groth S, Dirksen A, Dirksen H, Rossing N. Intraindividual variation and effect of learning in lung function examinations: a population study. Bull Eur Physiopathol Respir 1986;22(1):35-42.